– NETHERLANDS, La Hague – Aegon (AEX: AGN) today announced that Thomas Wellauer will be nominated for appointment to the Supervisory Board for a four-year term.
“We would like to welcome Thomas to the Supervisory Board and look forward to working with him. His international experience and in-depth knowledge of the insurance industry will be of great value to the board”, said William Connelly, chairman of Aegon’s Supervisory Board.
Robert W. Dineen has decided to step down as a member of the Supervisory Board in light of his appointment as Non‑Executive Chairman of First Eagle, a U.S. investment manager, and is stepping down as of today.
William Connelly: “We would like to thank Robert for his contribution to the Supervisory Board and its various committees. He brought valuable insights based on his extensive experience in the financial industry”.
About Thomas Wellauer
Mr Wellauer has been selected thanks to his international experience in the insurance industry, most recently as COO of Swiss Re, a global reinsurance company. The proposal for appointment of Mr Wellauer has been approved by the Dutch Central Bank (DNB) and will be submitted for approval at the next AGM on May 15, 2020.
About Aegon
Aegon’s roots go back 175 years – to the first half of the nineteenth century. Since then, Aegon has grown into an international company, with businesses in more than 20 countries in the Americas, Europe and Asia. Today, Aegon is one of the world’s leading financial services organizations, providing life insurance, pensions and asset management. Aegon’s purpose is to help people achieve a lifetime of financial security.
For more information: https://www.aegon.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
